Free Trial

Coeptis Therapeutics (COEPW) SEC Filings & 10K Form

$0.01 0.00 (-10.00%)
Closing price 03/31/2025 03:56 PM Eastern
Extended Trading
$0.01 0.00 (-21.30%)
As of 03/31/2025 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coeptis Therapeutics SEC Filings

DateFilerForm TypeView
03/27/2025
4:15 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
8:23 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Deschamps Philippe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:26 PM
Calise Chris (Reporting)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:26 PM
Cochran Christopher P. (Reporting)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:27 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
DeSilva Tara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:27 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Mehalick David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:28 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Salkind Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:28 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Sheehy Christine Elise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:29 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Yerace Daniel Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:29 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Cogley Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:46 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form S-1/A
01/22/2025
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 424B3
11/22/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 424B3
11/06/2024
3:40 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:30 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:00 AM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:01 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 424B3
08/16/2024
3:02 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 424B3
08/15/2024
7:16 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 10-Q/A
08/15/2024
7:17 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 10-K/A
08/15/2024
7:18 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 10-Q/A
08/15/2024
7:19 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:25 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:26 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form NT 10-Q
06/27/2024
2:04 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:COEPW) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners